Lifestyle trends and health tips
In this edition of STAT's AI Prognosis: A conversation with Insitro CEO Daphne Koller on artificial intelligence in drug discovery, and other health AI news.
Recent findings highlight the surprising surge in health care costs for major companies, prompting scrutiny and reevaluation of existing healthcare strategies.
A notable drop in GLP-1 drug coverage among U.S. employers coincides with a decline in Massachusetts' biotech workforce, highlighting industry challenges.
A new wave of drug trials aims to tackle genetic heart disease risk factors, particularly targeting Lp(a), with major implications for the pharmaceutical market.
Addressing women's health disparities could generate significant economic gains, with estimates suggesting a $1 trillion boost worldwide by 2040.
Recent analyses indicate that post-Dobbs predictions about abortion rates and health impacts may not align with current realities.
Roche's significant investment in the U.S. coincides with heightened demand for estrogen patches, now facing severe production challenges.
With Ebola cases rising sharply in the DRC, Merck's vaccine is set for deployment to enhance response efforts, including a significant clinical trial.
Focal therapy is increasingly considered in prostate cancer treatment, offering a targeted approach with fewer side effects than traditional methods.
Lil Nas X's bipolar diagnosis highlights a troubling paradox where acknowledgment of distress often clashes with the pursuit of success and treatment fears.
Long-term HIV survivors worry that a cure might jeopardize their essential support services, highlighting the need for thoughtful policy considerations.
Regeneron and Ultragenyx receive FDA approvals for significant therapies aimed at rare diseases, offering new hope for affected patients.
Healthcare providers are increasingly adopting AI chatbots to navigate complex patient records, improving diagnosis and patient care.
Erica Schwartz, the new CDC director, emphasizes transparency and empowerment in her inaugural address, ready to challenge administration leaders as needed.
STAT launches strategic roles and initiatives to combat misinformation and rebuild public trust in science, led by seasoned journalist Nicholas Florko.
A Harvard team has kept brain organoids alive for over five years, revealing developmental insights that advance our understanding of human brains.
Epic's annual meeting revealed new customer partnerships and engaging presentations, but left attendees wanting more on AI developments.
Elisabeth Marnik transformed her life by embracing vaccinations, using her own journey to advocate for science communication and understanding diverse perspectives.
The potential removal of racism from public health competencies raises fears of undermining efforts to address systemic inequities and health disparities.
The FTC is investigating Epic Systems for potential antitrust violations related to its market dominance and employment contracts.